Drewes G, Mandelkow E M, Baumann K, Goris J, Merlevede W, Mandelkow E
Max-Planck Unit for Struct. Mol. Biol., Hamburg, Germany.
FEBS Lett. 1993 Dec 28;336(3):425-32. doi: 10.1016/0014-5793(93)80850-t.
We have shown previously that brain tissue contains protein kinases which can phosphorylate tau protein to a state reminiscent of the pathological state of Alzheimer paired helical filaments (PHFs); these include proline-directed kinases which phosphorylate SP or TP motifs (such as MAP kinase and GSK-3) [Drewes et al. (1992); Mandelkow et al. (1992)], as well as a novel kinase which phosphorylates S262 of tau protein and thereby strongly reduces the binding of tau to microtubules [Biernat et al. (1993)]. Here we report on the corresponding phosphatases in brain which normally keep the 'pathological' sites free of phosphate. The major phosphatases acting on tau are calcineurin and PP-2A, but not PP-1. Both are present and active in brain extracts, they can dephosphorylate recombinant tau after prior phosphorylation with either MAP kinase, GSK-3, or brain extract, and the course of dephosphorylation can be monitored with antibodies diagnostic of the pathological state of tau. Both phosphatases also act directly on PHF tau isolated from Alzheimer brains.
我们之前已经表明,脑组织中含有蛋白激酶,这些激酶可将tau蛋白磷酸化至类似于阿尔茨海默病成对螺旋丝(PHF)病理状态的一种状态;其中包括能磷酸化SP或TP基序的脯氨酸定向激酶(如丝裂原活化蛋白激酶和糖原合成酶激酶-3)[德鲁斯等人(1992年);曼德科夫等人(1992年)],以及一种新型激酶,它可磷酸化tau蛋白的S262位点,从而强烈降低tau与微管的结合[比尔纳特等人(1993年)]。在此,我们报告脑组织中相应的磷酸酶,它们通常使“病理”位点保持无磷酸状态。作用于tau的主要磷酸酶是钙调神经磷酸酶和蛋白磷酸酶2A,而非蛋白磷酸酶1。这两种磷酸酶在脑提取物中均存在且具有活性,在用丝裂原活化蛋白激酶、糖原合成酶激酶-3或脑提取物进行预先磷酸化后,它们能使重组tau去磷酸化,并且可以用诊断tau病理状态的抗体监测去磷酸化过程。这两种磷酸酶也直接作用于从阿尔茨海默病大脑中分离出的PHF tau。